2-(1H-tetrazol-1-yl)-6,7-dihydro-5H-cyclopenta[b]pyridine-5-carboxylic acid → 2-(1H-tetrazol-1-yl)-6,7-dihydro-5H-cyclopenta[d]pyrimidine-6-carboxylic acid
반응식
[N:1]1([C:6]2[N:7]=[CH:8][C:9]3[CH2:14][CH:13]([C:15]([O:17]C)=[O:16])[CH2:12][C:10]=3[N:11]=2)[CH:5]=[N:4][N:3]=[N:2]1.N1(C2N=C3CCC(C(O)=O)C3=CC=2)C=NN=N1>>[N:1]1([C:6]2[N:7]=[CH:8][C:9]3[CH2:14][CH:13]([C:15]([OH:17])=[O:16])[CH2:12][C:10]=3[N:11]=2)[CH:5]=[N:4][N:3]=[N:2]1참가 물질
3
실험 절차
The title compound was prepared from methyl 2-(1H-tetrazol-1-yl)-6,7-dihydro-5H-cyclopenta[d]pyrimidine-6-carboxylate in an analogous fashion to that described in Step F of the synthesis of 2-(1H-tetrazol-1-yl)-6,7-dihydro-5H-cyclopenta[b]pyridine-5-carboxylic acid.
출처 및 근거
- ORD 기록
- ord-eeb90a7e098241e4ba83029b32277983
- 출처 데이터셋
- uspto-grants-2015_06
- 특허 번호
- US09062070B2
반응 노트
불러오는 중…